Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cheng-Bo Han

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Cancer Medicine|October 3, 2024
The Optimal First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer Based on Liver Metastasis Status: A Network Meta-Analysis and Systematic ReviewShu-Ling Zhang, Jing Yu, Yuan Tian, et al.
Nuclear Medicine Communications|December 11, 2013
Detection of residual tumor following radiofrequency ablation of liver metastases using 18F-FDG PET/PET-CT: a systematic review and meta-analysisJia-He Zheng, Zhi-Hui Chang, Cheng-Bo Han, et al.
Lung Cancer (Amsterdam, Netherlands)|April 26, 2024
Is neoadjuvant immunotherapy necessary in patients with programmed death ligand 1 expression-negative resectable non-small cell lung cancer? A systematic review and meta-analysisShu-Ling Zhang, Yuan Tian, Jing Yu, et al.
Lung|September 15, 2014
The influence of mtDNA deletion on lung cancer cells under the conditions of hypoxia and irradiationCheng-Bo Han, Li Sun, Jie-Tao Ma, et al.
World Journal of Gastroenterology|December 21, 2004
Mutations of mitochondrial 12S rRNA in gastric carcinoma and their significanceCheng-Bo Han, Jia-Ming Ma, Yan Xin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 27, 2023
Dual antitumor immunomodulatory effects of PARP inhibitor on the tumor microenvironment: A counterbalance between anti-tumor and pro-tumorXiao-Fang Yi, Ruo-Lin Gao, Li Sun, et al.
Cancer Medicine|July 13, 2019
Rational application of the first-line chemotherapy and immune checkpoint inhibitors in advanced nonsmall cell lung cancer: A meta-analysisRui Cao, Jie-Tao Ma, Shu-Ling Zhang, et al.
Biomed Research International|February 12, 2021
Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-AnalysisJie-Tao Ma, Yi-Jia Guo, Jun Song, et al.
Journal of Cancer|August 17, 2019
Effects of Dynamin-related Protein 1 Regulated Mitochondrial Dynamic Changes on Invasion and Metastasis of Lung Cancer CellsJie-Tao Ma, Xiang-Yan Zhang, Rui Cao, et al.
Molecular Cancer|November 20, 2024
Targeting mitochondria: restoring the antitumor efficacy of exhausted T cellsMei-Qi Yang, Shu-Ling Zhang, Li Sun, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Cancer Medicine|October 3, 2024
The Optimal First-Line Therapy for Extensive-Stage Small-Cell Lung Cancer Based on Liver Metastasis Status: A Network Meta-Analysis and Systematic ReviewShu-Ling Zhang, Jing Yu, Yuan Tian, et al.
Nuclear Medicine Communications|December 11, 2013
Detection of residual tumor following radiofrequency ablation of liver metastases using 18F-FDG PET/PET-CT: a systematic review and meta-analysisJia-He Zheng, Zhi-Hui Chang, Cheng-Bo Han, et al.
Lung Cancer (Amsterdam, Netherlands)|April 26, 2024
Is neoadjuvant immunotherapy necessary in patients with programmed death ligand 1 expression-negative resectable non-small cell lung cancer? A systematic review and meta-analysisShu-Ling Zhang, Yuan Tian, Jing Yu, et al.
Lung|September 15, 2014
The influence of mtDNA deletion on lung cancer cells under the conditions of hypoxia and irradiationCheng-Bo Han, Li Sun, Jie-Tao Ma, et al.
World Journal of Gastroenterology|December 21, 2004
Mutations of mitochondrial 12S rRNA in gastric carcinoma and their significanceCheng-Bo Han, Jia-Ming Ma, Yan Xin, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|April 27, 2023
Dual antitumor immunomodulatory effects of PARP inhibitor on the tumor microenvironment: A counterbalance between anti-tumor and pro-tumorXiao-Fang Yi, Ruo-Lin Gao, Li Sun, et al.
Cancer Medicine|July 13, 2019
Rational application of the first-line chemotherapy and immune checkpoint inhibitors in advanced nonsmall cell lung cancer: A meta-analysisRui Cao, Jie-Tao Ma, Shu-Ling Zhang, et al.
Biomed Research International|February 12, 2021
Rational Application of First-Line EGFR-TKIs Combined with Antiangiogenic Inhibitors in Advanced EGFR-Mutant Non-Small-Cell Lung Cancer: A Systematic Review and Meta-AnalysisJie-Tao Ma, Yi-Jia Guo, Jun Song, et al.
Journal of Cancer|August 17, 2019
Effects of Dynamin-related Protein 1 Regulated Mitochondrial Dynamic Changes on Invasion and Metastasis of Lung Cancer CellsJie-Tao Ma, Xiang-Yan Zhang, Rui Cao, et al.
Molecular Cancer|November 20, 2024
Targeting mitochondria: restoring the antitumor efficacy of exhausted T cellsMei-Qi Yang, Shu-Ling Zhang, Li Sun, et al.
Pageof 5